^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    PECAM1 underexpression

    i
    Other names: PECAM1, Platelet And Endothelial Cell Adhesion Molecule 1, CD31 Antigen, CD31, Platelet Endothelial Cell Adhesion Molecule, PECAM-1, EndoCAM, GPIIA, PECA1, Platelet/Endothelial Cell Adhesion Molecule 1, Platelet Endothelial Cell Adhesion Molecule-1, CD31/EndoCAM
    Entrez ID:
    5175
    2years
    Expression and clinical significance of PD-L1 and infiltrated immune cells in the gastric adenocarcinoma microenvironment. (PubMed, Medicine (Baltimore))
    The findings indicate that patients with high PD-L1 expression in immune cells have a substantially improved prognosis. Additionally, the combination of PD-L1 with CD8 or CD31 expression status can serve as an indicator of prognosis in patients with gastric adenocarcinoma.
    Journal • PD(L)-1 Biomarker • IO biomarker • Immune cell
    |
    PD-L1 (Programmed death ligand 1) • CD19 (CD19 Molecule) • CD8 (cluster of differentiation 8) • CD4 (CD4 Molecule) • NCAM1 (Neural cell adhesion molecule 1) • CD68 (CD68 Molecule) • CD31 (Platelet and endothelial cell adhesion molecule 1) • ITGAX (Integrin Subunit Alpha X) • PECAM1 (Platelet And Endothelial Cell Adhesion Molecule 1)
    |
    PD-L1 expression • PD-L1 overexpression • CD19 expression • CD31 expression • PECAM1 underexpression